424 related articles for article (PubMed ID: 38044048)
1. [Expert consensus on the management of interstitial lung disease during the COVID-19 epidemic].
Respiratory Council of Chinese Research Hospital Association
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1204-1218. PubMed ID: 38044048
[TBL] [Abstract][Full Text] [Related]
2. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
3. [Chinese expert consensus on multidisciplinary discussion of interstitial lung disease].
;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1176-1188. PubMed ID: 37989522
[TBL] [Abstract][Full Text] [Related]
4. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
[TBL] [Abstract][Full Text] [Related]
5. Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
Rahaghi FF; Hsu VM; Kaner RJ; Mayes MD; Rosas IO; Saggar R; Steen VD; Strek ME; Bernstein EJ; Bhatt N; Castelino FV; Chung L; Domsic RT; Flaherty KR; Gupta N; Kahaleh B; Martinez FJ; Morrow LE; Moua T; Patel N; Shlobin OA; Southern BD; Volkmann ER; Khanna D
Respir Res; 2023 Jan; 24(1):6. PubMed ID: 36624431
[TBL] [Abstract][Full Text] [Related]
6. [Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome].
; ; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Sep; 46(9):897-908. PubMed ID: 37670643
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
10. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
11. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
[TBL] [Abstract][Full Text] [Related]
13. [Expert recommendations for the diagnosis and treatment of interstitial lung disease caused by novel coronavirus pneumonia].
;
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Oct; 43(10):827-833. PubMed ID: 32992435
[TBL] [Abstract][Full Text] [Related]
14. [Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].
Rodríguez A; Alvarez-Rocha L; Sirvent JM; Zaragoza R; Nieto M; Arenzana A; Luque P; Socías L; Martín M; Navarro D; Camarena J; Lorente L; Trefler S; Vidaur L; Solé-Violán J; Barcenilla F; Pobo A; Vallés J; Ferri C; Martín-Loeches I; Díaz E; López D; López-Pueyo MJ; Gordo F; del Nogal F; Marqués A; Tormo S; Fuset MP; Pérez F; Bonastre J; Suberviola B; Navas E; León C; ; ;
Med Intensiva; 2012 Mar; 36(2):103-37. PubMed ID: 22245450
[TBL] [Abstract][Full Text] [Related]
15. Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis.
Yu KH; Chen HH; Cheng TT; Jan YJ; Weng MY; Lin YJ; Chen HA; Cheng JT; Huang KY; Li KJ; Su YJ; Leong PY; Tsai WC; Lan JL; Chen DY
Medicine (Baltimore); 2022 Jan; 101(1):e28501. PubMed ID: 35029907
[TBL] [Abstract][Full Text] [Related]
16. International guidelines for groin hernia management.
HerniaSurge Group
Hernia; 2018 Feb; 22(1):1-165. PubMed ID: 29330835
[TBL] [Abstract][Full Text] [Related]
17. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
[TBL] [Abstract][Full Text] [Related]
18. Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic.
Shao C; Shi Y; Chen R; Liu X; Huang H; Zhao Y; Xu K; Chen K; Wang M; Xu Z
J Med Virol; 2023 Sep; 95(9):e29098. PubMed ID: 37707416
[TBL] [Abstract][Full Text] [Related]
19. The Role of Pulmonary Function Testing and Lung Imaging in the Long-Term Follow-Up of Patients with COVID-19 Pneumonia.
Sanna A; Pellegrino D; Messina E; Siena LM; Baccolini V; D'Antoni L; Landini N; Baiocchi P; Villari P; Catalano C; Panebianco V; Palange P
Respiration; 2023; 102(4):287-295. PubMed ID: 36806049
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease.
Smits B; Goldacker S; Seneviratne S; Malphettes M; Longhurst H; Mohamed OE; Witt-Rautenberg C; Leeman L; Schwaneck E; Raymond I; Meghit K; Uhlmann A; Winterhalter C; van Montfrans J; Klima M; Workman S; Fieschi C; Lorenzo L; Boyle S; Onyango-Odera S; Price S; Schmalzing M; Aurillac V; Prasse A; Hartmann I; Meerburg JJ; Kemner-van de Corput M; Tiddens H; Grimbacher B; Kelleher P; Patel SY; Korganow AS; Viallard JF; Tony HP; Bethune C; Schulze-Koops H; Witte T; Huissoon A; Baxendale H; Grigoriadou S; Oksenhendler E; Burns SO; Warnatz K
J Allergy Clin Immunol; 2023 Aug; 152(2):528-537. PubMed ID: 36587851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
